Articles tagged "Scales"

MDS Virtual Congress 2020
The Progressive Supranuclear Palsy Clinical Deficits Scale
G. Respondek, I. Piot, K. Schweyer, M. Stamelou, P. Sckopke, T. Schenk, C. Goetz, T. Stebbins, G. Höglinger (Hannover, Germany)
Objective: To develop a scale to monitor clinical deficits in patients with Progressive Supranuclear Palsy across its broad phenotypes. Background: There is currently no undisputed,…
MDS Virtual Congress 2020
Toward the digitization of the International Parkinson and Movement Disorder Society rating scales
M. Monje, R. Fuller, E. Cubo, T. Mestre, A. Tan, J. Stout, S. Ali, L. Chahine, K. Dujardin, C. Fitzer-Attas, J. Youn, B. Bloem, F. Horak, A. Merola, R. Reilmann, S. Paul, R. Dorsey, W. Maetzler, A. Espay, P. Martinez-Martin, G. Stebbins, A. Sánchez-Ferro (Móstoles, Madrid, Spain)
Objective: Create recommendations for the electronic use of rating scales (e-scaled) owned or managed by the International Parkinson and Movement Disorder Society (MDS). Background: Medicine…
2019 International Congress
Prevalence of chronic kidney disease in patients with idiopathic Parkinson’s disease in a tertiary care hospital in Mexico City
S. Isais-Millan, CA. Rojas-Guerrero, A. Arriaga, M. Rodriguez-Violante, D. Zuñiga-Garcia, RO. Millan-Guerrero, V. Campos-Gasga, V. Garcia-Barrera, R. Santos-Montero (Colima, Mexico)
Objective: To describe the prevalence of chronic kidney disease (CKD) in patients with idiopathic Parkinson's disease (PD) and to determine the association between renal function…
2019 International Congress
Quantitative EEG measures reflect general cognitive status in Parkinson’s disease
C. Navarro-Roa, M. Rodriguez-Violante, G. Sanchez-Dinorin, A. Cervantes-Arriaga, R. Solis-Vivanco (Mexico City, Mexico)
Objective: To explore the utility of the quantitative electroencephalogram (EEG) as a potential biomarker of cognitive status in patients with Parkinson's disease (PD). Background: While…
2019 International Congress
Preliminary validation of a novel, comprehensive digital biomarker smartphone application to assess motor symptoms in de-novo diagnosed Parkinson patients
F. Lipsmeier, K. Taylor, E. Volkova-Volkmar, R. Postuma, T. Kilchenmann, D. Wolf, Y. Zhang, W. Cheng, A. Scotland, J. Schjodt-Eriksen, F. Boess, D. Ness, C. Gossens, A. Post, M. Lindemann (Basel, Switzerland)
Objective: To determine the reliability and validity of a novel, comprehensive digital biomarker remote monitoring approach to actively and passively measure motor symptom progression in…
2019 International Congress
Use of e-PROMs in Parkinson’s disease clinics: A qualitative study of healthcare professionals perceptions
A. Khardali, L. Hughes, E. Lane (Cardiff, United Kingdom)
Objective: To explore the views of PD healthcare professionals on the use of e-PROMs. Background: Assessment of motor AND non-motor symptoms are critical to the…
2019 International Congress
Reliability, feasibility and validity of a novel digital monitoring platform assessing cognitive and motor symptoms in people with Stage I and II Huntington’s disease (HD)
F. Lipsmeier, C. Simillion, A. Atieh Bamdadian, A. Smith, S. Schobel, C. Gossens, P. Weydt, E. Wild, M. Lindemann (Basel, Switzerland)
Objective: To determine the reliability and convergent validity of a novel digital monitoring platform offering objective, daily assessment of cognitive and motor symptom severity in…
2019 International Congress
Digital biomarker sensor feature data reflect quality of life judgements (PDQ39) in recently diagnosed Parkinson’s disease patients
F. Lipsmeier, K. Taylor, E. Volkova-Volkmar, H. Staunton, R. Postuma, T. Kilchenmann, D. Wolf, Y. Zhang, WY. Cheng, A. Scotland, J. Schjodt-Eriksen, F. Boess, D. Ness, C. Gossens, A. Post, M. Lindemann (Basel, Switzerland)
Objective: To evaluate the extent to which data derived from smartphone-based testing and passive monitoring are related to what recently diagnosed Parkinson’s disease (PD) patients…
2019 International Congress
How reliable are non-blinded evaluations of motor UPDRS? a comparison of blinded vs. un-blinded UPDRS scores in 14 patients with advanced Parkinson´s disease
G-M. Hariz, A. Fredricks, R. Stenmark, J. Linder, M. Hariz, L. Forsgren, P. Blomstedt (Umea, Sweden)
Objective: To investigate the reliability of scores of the motor part of the Unified Parkinson Disease Rating Scale (UPDRS III) rated by an un-blinded specialist…
2019 International Congress
Digital monitoring of Huntington’s disease with smartphone and smartwatch wearable technology: The Digital-HD study
R. Tortelli, T. Kilchenmann, F. Rodrigues, L. Byrne, A. Bamdadian, F. Lipsmeier, S. Schobel, M. Lindemann, E. Wild (London, United Kingdom)
Objective: To investigate the tolerability and feasibility of using wearable smartphone and smartwatch technologies to monitor the motor, behavioural, cognitive and quality of life (QoL)…